bioLytical Laboratories Inc. Receives Health Canada Authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test
bioLytical Laboratories Inc. Receives Health Canada Authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test bioLytical Laboratories Inc. announced today that it has launched its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test for professional use in Canada GlobeNewswire March 27, 2023 bioLytical has received Health Canada authorization to sell its INSTI® Multiplex HIV-1/2...